دورية أكاديمية
A-305 - A Phase 1 study of fianlimab in combination with cemiplimab in patients with anti–PD-1/L1-experienced cutaneous squamous cell carcinoma
العنوان: | A-305 - A Phase 1 study of fianlimab in combination with cemiplimab in patients with anti–PD-1/L1-experienced cutaneous squamous cell carcinoma |
---|---|
المؤلفون: | Kaczmar, J., Papadopoulos, K., Ansstas, G., Birnbaum, A., Mehnert, J., Hamid, O., Hughes, B., Rabinowits, G., Wei, A., Yushak, M., Mani, J., Fang, F., Wang, J., Kroog, G., Salvati, M., Lowy, I., Fury, M., Lakhani, N.J. |
المصدر: | In EJC Skin Cancer 2024 2 Supplement 1 |
قاعدة البيانات: | ScienceDirect |
تدمد: | 27726118 |
---|---|
DOI: | 10.1016/j.ejcskn.2024.100213 |